First Equity Adjusts Stake in Theracryf PLC

Evgen Pharma (GB:TCF) has released an update.

First Equity Limited, an investment firm based in London, has altered its stakes in Theracryf PLC, crossing a threshold on June 12, 2024, which resulted in a change in their total voting rights from 5.896849% to 4.797040% of the company. The notification, which includes details of direct voting rights and the controlling entities involved, indicates a significant transaction that could interest investors tracking ownership changes in UK-based companies.

For further insights into GB:TCF stock, check out TipRanks’ Stock Analysis page.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.